These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15653707)

  • 1. Impact of peripheral elimination on the concentration-effect relationship of remifentanil in anaesthetized dogs.
    Kabbaj M; Vachon P; Varin F
    Br J Anaesth; 2005 Mar; 94(3):357-65. PubMed ID: 15653707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics.
    Hermann DJ; Egan TD; Muir KT
    Clin Pharmacol Ther; 1999 May; 65(5):511-8. PubMed ID: 10340916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
    Chism JP; Rickert DE
    Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.
    Egan TD; Minto CF; Hermann DJ; Barr J; Muir KT; Shafer SL
    Anesthesiology; 1996 Apr; 84(4):821-33. PubMed ID: 8638836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery.
    Westmoreland CL; Hoke JF; Sebel PS; Hug CC; Muir KT
    Anesthesiology; 1993 Nov; 79(5):893-903. PubMed ID: 7902033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial and venous pharmacokinetics of morphine-6-glucuronide and impact of sample site on pharmacodynamic parameter estimates.
    Olofsen E; Mooren R; van Dorp E; Aarts L; Smith T; den Hartigh J; Dahan A; Sarton E
    Anesth Analg; 2010 Sep; 111(3):626-32. PubMed ID: 20547824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial muscle concentrations of rocuronium under steady-state conditions in anaesthetized dogs: actual versus predicted values.
    Ezzine S; Varin F
    Br J Anaesth; 2005 Jan; 94(1):49-56. PubMed ID: 15542539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.
    Egan TD; Lemmens HJ; Fiset P; Hermann DJ; Muir KT; Stanski DR; Shafer SL
    Anesthesiology; 1993 Nov; 79(5):881-92. PubMed ID: 7902032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of remifentanil during liver transplantation.
    Navapurkar VU; Archer S; Gupta SK; Muir KT; Frazer N; Park GR
    Br J Anaesth; 1998 Dec; 81(6):881-6. PubMed ID: 10211013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measured context-sensitive half-times of remifentanil and alfentanil.
    Kapila A; Glass PS; Jacobs JR; Muir KT; Hermann DJ; Shiraishi M; Howell S; Smith RL
    Anesthesiology; 1995 Nov; 83(5):968-75. PubMed ID: 7486182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair.
    Davis PJ; Wilson AS; Siewers RD; Pigula FA; Landsman IS
    Anesth Analg; 1999 Oct; 89(4):904-8. PubMed ID: 10512263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children.
    Jeleazcov C; Ihmsen H; Schmidt J; Ammon C; Schwilden H; Schüttler J; Fechner J
    Br J Anaesth; 2008 Apr; 100(4):509-16. PubMed ID: 18270231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4'-hydroxypropranolol in dogs.
    Muir WW; Sams RA; Schall SF
    J Vet Pharmacol Ther; 1996 Aug; 19(4):259-67. PubMed ID: 8866453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil.
    Dahaba AA; Oettl K; von Klobucar F; Reibnegger G; List WF
    Can J Anaesth; 2002 Apr; 49(4):369-74. PubMed ID: 11927475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cardiac output on the pseudo-steady state remifentanil and propofol concentrations in swine.
    Kurita T; Uraoka M; Jiang Q; Suzuki M; Morishima Y; Morita K; Sato S
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):754-60. PubMed ID: 23347138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic simulations of remifentanil].
    Masui K; Kazama T
    Masui; 2007 Nov; 56(11):1287-95. PubMed ID: 18027597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.
    Ross AK; Davis PJ; Dear Gd GL; Ginsberg B; McGowan FX; Stiller RD; Henson LG; Huffman C; Muir KT
    Anesth Analg; 2001 Dec; 93(6):1393-401, table of contents. PubMed ID: 11726413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.
    Tuk B; Danhof M; Mandema JW
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):39-62. PubMed ID: 9353693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal.
    Egan TD
    Clin Pharmacokinet; 1995 Aug; 29(2):80-94. PubMed ID: 7586903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesia.
    Lötsch J; Skarke C; Darimont J; Zimmermann M; Bräutigam L; Geisslinger G; Ultsch A; Oertel BG
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):865-73. PubMed ID: 23775505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.